|
1
|
Hu XT and He C: Recent progress in the
study of methylated tumor suppressor genes in gastric cancer. Chin
J Cancer. 32:31–41. 2013. View Article : Google Scholar :
|
|
2
|
Yang XB, Zhao JJ, Huang CY, Wang QJ, Pan
K, Wang DD, Pan QZ, Jiang SS, Lv L, Gao X, et al: Decreased
expression of the FOXO3a gene is associated with poor prognosis in
primary gastric adenocarcinoma patients. PLoS One. 8:e781582013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wogan GN, Hecht SS, Felton JS, Conney AH
and Loeb LA: Environmental and chemical carcinogenesis. Semin
Cancer Biol. 14:473–486. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buffart TE, Tijssen M, El-Bchiri J, Duval
A, van de Wiel MA, Ylstra B, Meijer GA and Carvalho B: NMD
inhibition fails to identify tumour suppressor genes in
microsatellite stable gastric cancer cell lines. BMC Med Genomics.
2:392009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Friday BB and Adjei AA: K-ras as a target
for cancer therapy. Biochim Biophys Acta. 1756:127–144.
2005.PubMed/NCBI
|
|
6
|
Bah N, Maillet L, Ryan J, Dubreil S,
Gautier F, Letai A, Juin P and Barillé-Nion S: Bcl-xL controls a
switch between cell death modes during mitotic arrest. Cell Death
Dis. 5:e12912014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan MJ and Wang T: Advances of the
interleukin-21 signaling pathway in immunity and angiogenesis.
Biomed Rep. 5:3–6. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cha Z, Gu H, Guo H, Tu X, Zang Y, Zhao C,
Hua M, Rechlic JR, Olasnova LM, Song H, et al: Effect of
interleukin 21 and its receptor on CD8+ T cells in the
pathogenesis of diffuse large B-cell lymphoma. Oncol Lett.
8:421–425. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Browning RL, Mo X, Muthusamy N and Byrd
JC: CpG oligo-deoxynucleotide CpG-685 upregulates functional
interleukin-21 receptor on chronic lymphocytic leukemia B cells
through an NF-κB mediated pathway. Oncotarget. 6:15931–15939. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wood B, Sikdar S, Choi SJ, Virk S,
Alhejaily A, Baetz T and LeBrun DP: Abundant expression of
interleukin-21 receptor in follicular lymphoma cells is associated
with more aggressive disease. Leuk Lymphoma. 54:1212–1220. 2013.
View Article : Google Scholar
|
|
11
|
Zhang M, Mathews Griner LA, Ju W, Duveau
DY, Guha R, Petrus MN, Wen B, Maeda M, Shinn P, Ferrer M, et al:
Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL
blockade in IL-2-dependent adult T-cell leukemia. Proc Natl Acad
Sci USA. 112:12480–12485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hao Y, Chapuy B, Monti S, Sun HH, Rodig SJ
and Shipp MA: Selective JAK2 inhibition specifically decreases
Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in
vitro and in vivo. Clin Cancer Res. 20:2674–2683. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang Z, Zhang L, Liao Q, Wang Y, Yu F,
Feng M, Xiang X and Xiong J: Regulation of TRIM24 by miR-511
modulates cell proliferation in gastric cancer. J Exp Clin Cancer
Res. 36:172017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding L, Zhang S, Xu M, Zhang R, Sui P and
Yang Q: MicroRNA-27a contributes to the malignant behavior of
gastric cancer cells by directly targeting PH domain and
leucinerich repeat protein phosphatase 2. J Exp Clin Cancer Res.
36:452017. View Article : Google Scholar
|
|
16
|
Tang Y, Cui Y, Li Z, Jiao Z, Zhang Y, He
Y, Chen G, Zhou Q, Wang W, Zhou X, et al: Radiation-induced
miR-208a increases the proliferation and radioresistance by
targeting p21 in human lung cancer cells. J Exp Clin Cancer Res.
35:72016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang R, Fu Y, Zeng Y, Xiang M, Yin Y, Li
L, Xu H, Zhong J and Zeng X: Serum miR-20a is a promising biomarker
for gastric cancer. Biomed Rep. 6:429–434. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Imaoka H, Toiyama Y, Okigami M, Yasuda H,
Saigusa S, Ohi M, Tanaka K, Inoue Y, Mohri Y and Kusunoki M:
Circulating microRNA-203 predicts metastases, early recurrence, and
poor prognosis in human gastric cancer. Gastric Cancer. 19:744–753.
2016. View Article : Google Scholar
|
|
19
|
Qu X, Zhou J, Wang T, Han J, Ma L, Yu H,
Geng D, Fan H, Zhang Q, Hua F, et al: MiR-30a inhibits Th17
differentiation and demyelination of EAE mice by targeting the
IL-21R. Brain Behav Immun. 57:193–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yun S, Lee SU, Kim JM, Lee HJ, Song HY,
Kim YK, Jung H, Park YJ, Yoon SR, Oh SR, et al: Integrated
mRNA-microRNA profiling of human NK cell differentiation identifies
MiR-583 as a negative regulator of IL2Rγ expression. PLoS One.
9:e1089132014. View Article : Google Scholar
|
|
21
|
Wang Y, Wang K, Dang N, Wang L and Zhang
M: Downregulation of miR-3940-5p promotes T-cell activity by
targeting the cytokine receptor IL-2R gamma on human cutaneous
T-cell lines. Immunobiology. 221:1378–1381. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Laneve P, Po A, Favia A, Legnini I, Alfano
V, Rea J, Di Carlo V, Bevilacqua V, Miele E, Mastronuzzi A, et al:
The long noncoding RNA linc-NeD125 controls the expression of
medulloblastoma driver genes by microRNA sponge activity.
Oncotarget. 8:31003–31015. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shao Y, Ye M, Li Q, Sun W, Ye G, Zhang X,
Yang Y, Xiao B and Guo J: LncRNA-RMRP promotes carcinogenesis by
acting as a miR-206 sponge and is used as a novel biomarker for
gastric cancer. Oncotarget. 7:37812–37824. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Wang G, Chu SJ, Zhu JS, Zhang R,
Lu WW, Xia LQ, Lu YM, Da W and Sun Q: Loss of large tumor
suppressor 1 promotes growth and metastasis of gastric cancer cells
through upregulation of the YAP signaling. Oncotarget.
7:16180–16193. 2016.PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu L, Wu Y, Tan D, Meng H, Wang K, Bai Y
and Yang K: Up-regulation of long noncoding RNA MALAT1 contributes
to proliferation and metastasis in esophageal squamous cell
carcinoma. J Exp Clin Cancer Res. 34:72015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Y, Wu Z, Yuan J, Sun L, Lin L, Huang N,
Bin J, Liao Y and Liao W: Long non-coding RNA MALAT1 promotes
gastric cancer tumorigenicity and metastasis by regulating
vasculogenic mimicry and angiogenesis. Cancer Lett. 395:31–44.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jadaliha M, Zong X, Malakar P, Ray T,
Singh DK, Freier SM, Jensen T, Prasanth SG, Karni R, Ray PS, et al:
Functional and prognostic significance of long non-coding RNA
MALAT1 as a metastasis driver in ER negative lymph node negative
breast cancer. Oncotarget. 7:40418–40436. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deng QJ, Xie LQ and Li H: Overexpressed
MALAT1 promotes invasion and metastasis of gastric cancer cells via
increasing EGFL7 expression. Life Sci. 157:38–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Davis ID, Skak K, Smyth MJ, Kristjansen
PE, Miller DM and Sivakumar PV: Interleukin-21 signaling: Functions
in cancer and autoimmunity. Clin Cancer Res. 13:6926–6932. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ueda M, Imada K, Imura A, Koga H,
Hishizawa M and Uchiyama T: Expression of functional interleukin-21
receptor on adult T-cell leukaemia cells. Br J Haematol.
128:169–176. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bolzoni M, Ronchetti D, Storti P, Donofrio
G, Marchica V, Costa F, Agnelli L, Toscani D, Vescovini R, Todoerti
K, et al: IL21R expressing CD14+CD16+ monocytes expand in multiple
myeloma patients leading to increased osteoclasts. Haematologica.
102:773–784. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
de Totero D, Meazza R, Zupo S, Cutrona G,
Matis S, Colombo M, Balleari E, Pierri I, Fabbi M, Capaia M, et al:
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering
and mediates proapoptotic signals in chronic lymphocytic leukemia B
cells. Blood. 107:3708–3715. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang LN, Cui YX, Ruge F and Jiang WG:
Interleukin 21 and its receptor play a role in proliferation,
migration and invasion of breast cancer cells. Cancer Genomics
Proteomics. 12:211–221. 2015.PubMed/NCBI
|
|
37
|
Yin F, Zhang JN, Wang SW, Zhou CH, Zhao
MM, Fan WH, Fan M and Liu S: MiR-125a-3p regulates glioma apoptosis
and invasion by regulating Nrg1. PLoS One. 10:e01167592015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pan L, Zhou L, Yin W, Bai J and Liu R:
miR-125a induces apoptosis, metabolism disorder and
migrationimpairment in pancreatic cancer cells by targeting
Mfn2-related mitochondrial fission. Int J Oncol. 53:124–136.
2018.PubMed/NCBI
|
|
39
|
Yan L, Yu MC, Gao GL, Liang HW, Zhou XY,
Zhu ZT, Zhang CY, Wang YB and Chen X: MiR-125a-5p functions as a
tumour suppressor in breast cancer by downregulating BAP1. J Cell
Biochem. Aug 4–2018.Epub ahead of print. View Article : Google Scholar
|
|
40
|
Bayoumi AS, Sayed A, Broskova Z, Teoh JP,
Wilson J, Su H, Tang YL and Kim IM: Crosstalk between Long
Noncoding RNAs and MicroRNAs in Health and Disease. Int J Mol Sci.
17:3562016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen L, Yao H, Wang K and Liu X: Long
non-coding RNA MALAT1 regulates ZEB1 expression by sponging
miR-143-3p and promotes hepatocellular carcinoma progression. J
Cell Biochem. 118:4836–4843. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hou Z, Xu X, Zhou L, Fu X, Tao S, Zhou J,
Tan D and Liu S: The long non-coding RNA MALAT1 promotes the
migration and invasion of hepatocellular carcinoma by sponging
miR-204 and releasing SIRT1. Tumour Biol. 39:10104283177181352017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li Z, Xu C, Ding B, Gao M, Wei X and Ji N:
Long non-coding RNA MALAT1 promotes proliferation and suppresses
apoptosis of glioma cells through derepressing Rap1B by sponging
miR-101. J Neurooncol. 134:19–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jiang LT, Wan CH, Guo QH, Yang SJ, Wu JD
and Cai J: Long noncoding RNA metastasis-associated lung
adenocarcinoma transcript 1 (MALAT1) promotes renal cell carcinoma
progression via sponging miRNA-429. Med Sci Monit. 24:1794–1801.
2018. View Article : Google Scholar : PubMed/NCBI
|
